SLM + Axitinib for Clear Cell RCC
Condition(s):Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)Last Updated:September 6, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)Last Updated:September 6, 2023Active, not recruiting
Condition(s):Renal Cell CarcinomaLast Updated:July 11, 2022Completed
Condition(s):Carcinoma, Renal CellLast Updated:June 6, 2023Active, not recruiting
Condition(s):VHL Gene Mutation; VHL; VHL Syndrome; VHL Gene Inactivation; Von Hippel; Von Hippel-Lindau Disease; Von Hippel’s Disease; Von Hippel-Lindau Syndrome, Modifiers of; Clear Cell Renal Cell Carcinoma; Clear Cell RCC; ccRCCLast Updated:December 22, 2023Completed
Condition(s):Carcinoma, Renal CellLast Updated:March 22, 2024Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:May 12, 2022Completed
Condition(s):Clear Cell Renal Cell Carcinoma (ccRCC); Melanoma; Non-small Cell Lung Cancer (NSCLC)Last Updated:March 17, 2023Terminated
Condition(s):ccRCC; RCC; Kidney Cancer; Clear Cell Renal Cell Carcinoma; Renal Cell CarcinomaLast Updated:January 12, 2024Active, not recruiting
Condition(s):Carcinoma, Renal CellLast Updated:March 24, 2023Recruiting
Condition(s):Carcinoma, Renal CellLast Updated:March 13, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.